PNV
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

PolyNovo Limited is a medical device company that develops and commercializes synthetic skin substitutes using its patented bioabsorbable polymer technology, NovoSorb. The company's primary product, NovoSorb BTM (Biodegradable Temporizing Matrix), is designed to support tissue repair in patients with full-thickness burns before biodegrading in situ into biocompatible by-products. PolyNovo serves healthcare professionals and clinicians globally and has secured regulatory clearances including the US FDA 510(K), Australian TGA registration, and European CE Mark. The company holds a contract with the US Biomedical Advanced Research and Development Authority (BARDA) to complete a pivotal trial for burn treatment. PolyNovo’s technology originated from a collaboration with CSIRO and Prof. John Greenwood, with the first patient treated in 2013 and commercialization beginning in 2015 following US clearance.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Health Care Equipment & Services Homepage polynovo.com
Sector Healthcare IR page investors.polynovo.com
Tags
synthetic skin substitutes, burn treatment, bioabsorbable polymers, tissue repair, medical devices, wound care, NovoSorb, NovoSorb BTM, Biodegradable Temporizing Matrix
Press page —

Metrics

Valuation  
Market cap A$ 625.213M
Market cap (USD) $ 429.569M
P/E 86.79
PEG —
P/BV 7.01
P/S 4.35
P/OCF 27.05
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE —
ROI —
ROIC —
Profit margin —
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 4.0%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 33.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Revenue 143.706M 127.243M 103.192M 65.241M 41.44M 29.158M 22.156M 13.349M 5.714M 3.759M 3.471M 140.721K 244.577K
Net profit — — 5.261M — -1.193M -4.605M -4.194M -3.19M -5.974M -5.006M -3.062M -1.302M -2.936M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Share price 0.92 1.2 2.45 1.55 1.35 — — — — — — — —
Price performance 12m -0.23 -0.51 0.58 0.15 — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

PolyNovo Limited (ticker PNV), listed in Australia.

ETFs Holding PolyNovo Limited

ETF Weight in ETF Shares Market value As of
AVDS 0.01% 91,286 $ 54.265K Nov 16, 2026
DFIS 0.00% 254,369 $ 155.036K Nov 12, 2026
DFAX 0.00% 37,108 $ 22.617K Nov 12, 2026
DFIC 0.00% 23,007 $ 14.023K Nov 12, 2026
DFAI 0.00% 14,903 $ 9,083.30 Nov 12, 2026